Tril stock price target
20 Feb 2020 For example, the Trillium Therapeutics Inc. (TSE:TRIL) share price has soared Unfortunately the longer term returns are not so good, with the stock falling companies with past earnings growth (and further growth forecast). 19 Feb 2020 0 equity research analysts rated the shares with a selling strategy, 7 gave a hold approach, 0 gave a purchase tip, 0 gave the firm a overweight 17 Mar 2020 The shares of Trillium Therapeutics Inc. (NASDAQ:TRIL) has been That day the Ladenburg Thalmann set price target on the stock to $18. 18 hours ago The shares of Trillium Therapeutics Inc. (NASDAQ:TRIL) has been That day the Ladenburg Thalmann set price target on the stock to $18. View live TRILLIUM THERAPEUTICS INC chart to track its stock's price action. Find market predictions, TRIL financials and market news. 14 Jan 2020 So, are the price targets on Tesla too low? "I'm a huge fan of the car. The stockI' ve missed the move. So it's just too hard to Trillium Therapeutics Inc. (TRIL) Company Bio. Trillium Therapeutics develops therapies for the treatment of cancer. The company was founded in 2004 and is
View live TRILLIUM THERAPEUTICS INC chart to track its stock's price action. Find market predictions, TRIL financials and market news.
Their average twelve-month price target is $4.00, suggesting that the stock has a possible upside of 9.29%. The high price target for TRIL is $4.00 and the low 2 equities research analysts have issued 1-year price objectives for Trillium Therapeutics' stock. Their forecasts range from $4.00 to $4.00. On average, they Based on 4 analysts offering 12 month price targets for Trillium Therapeutics in the last 3 months. The average price target is $10.00 with a high forecast of Analyst price targets provided by TipRanks. Quick Links. Advanced Charting · After Hours Quote · Analyst Research Trillium Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. TRIL updated stock price target summary.
Tril Stock Forecast: up to 7.625 USD! - TRIL Stock Price ...
Find the latest Trillium Therapeutics Inc. (TRIL) stock quote, history, news and other vital information to help you with your stock trading and investing. TRIL | Trillium Therapeutics Inc. Analyst Estimates ... Trillium Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. TRIL updated stock price target summary. TRIL Stock Price, Forecast & News (Trillium Therapeutics) Analyzing Trillium Therapeutics (NASDAQ:TRIL) stock? View TRIL's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. Trillium Therapeutics Inc. Common Shares (TRIL) Stock ... Trillium Therapeutics Inc. Common Shares (TRIL) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
TRIL:Toronto Stock Quote - Trillium Therapeutics Inc ...
View detailed financial information, real-time news, videos, quotes and analysis on Trillium Therapeutics Inc. (NASDAQ:TRIL). Explore commentary on Trillium Therapeutics Inc. and hear what the Expensive Market, What To Buy? Trillium Therapeutics Inc ...
Mar 09, 2020 · This recent development has seen its 12-month potential target price placed at $11.02, which means that it is expected to increase by 52.63% from its current price. Of the 2 Wall Street analysts that rated the stock, 50% (1 analysts) have rated TRIL as a Buy while the remaining 50% (1 analysts) rated it as a Hold, with 0% (0 analysts) rated the
TRIL - Trillium Therapeutics Inc Stock quote - CNNMoney.com Find real-time TRIL - Trillium Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. TRIL - Trillium Therapeutics Inc Stock quote - CNNMoney.com Markets TRIL:Toronto Stock Quote - Trillium Therapeutics Inc ... Stock analysis for Trillium Therapeutics Inc (TRIL:Toronto) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Trillium Therapeutics Inc. Common Shares (TRIL) Analyst ...
Consensus Analyst Stock Ratings Creep Up: iBio, Inc. (IBIO ...